CHR ORLEANS - Hématologie

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia2 trials

Phase

• Phase 22 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• French Innovative Leukemia Organisation2 trials

Running trials

• Active, not recruiting

  STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia

  NCT04963946· Phase 2· French Innovative Leukemia Organisation· Source

Closed trials

• Completed

  Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia

  NCT04010968· Phase 2· French Innovative Leukemia Organisation· Source